Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). [PDF]
Drug Testing and Analysis, 2016 1-Propionyl-d-lysergic acid diethylamide hemitartrate (1P-LSD) has become available as a 'research chemical' in the form of blotters and powdered material.
Brandt, SD +7 more
core +2 more sources
Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide [PDF]
Journal of Psychopharmacology, 2016 This paper reports on the effects of LSD on mental time travel during spontaneous mentation. Twenty healthy volunteers participated in a placebo-controlled crossover study, incorporating intravenous administration of LSD (75 μg) and placebo (saline ...
Cohen S +14 more
core +3 more sources
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD). [PDF]
J Psychopharmacol, 2022 Background: Recreational lysergic acid diethylamide (LSD) use is growing in popularity amid increasing research interest on psychedelics and their possible therapeutic potential yet; the potent psychotropic effects of LSD may result in adverse reactions ...
Kopra EI +6 more
europepmc +2 more sources
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. [PDF]
Neuropsychopharmacology, 2022 Growing interest has been seen in using lysergic acid diethylamide (LSD) and psilocybin in psychiatric research and therapy. However, no modern studies have evaluated differences in subjective and autonomic effects of LSD and psilocybin or their ...
Holze F +12 more
europepmc +2 more sources
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity. [PDF]
Neuropsychopharmacology, 2023 Glazer J +4 more
europepmc +2 more sources
Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. [PDF]
Psychol Med, 2023 The non-selective serotonin 2A (5-HT2A) receptor agonist lysergic acid diethylamide (LSD) holds promise as a treatment for some psychiatric disorders. Psychedelic drugs such as LSD have been suggested to have therapeutic actions through their effects on ...
Kanen JW +7 more
europepmc +2 more sources
The Use of Lysergic Acid in Individual Psychotherapy [PDF]
Proceedings of the Royal Society of Medicine, 1960 T. M. Ling, J. Buckman
openaire +4 more sources
Independent Evolution of a Lysergic Acid Amide in Aspergillus Species. [PDF]
Appl Environ Microbiol, 2021 Lysergic acid derivatives are specialized metabolites with historical, agricultural, and medical significance and were known heretofore only from fungi in one family, the Clavicipitaceae.
Jones AM, Steen CR, Panaccione DG.
europepmc +2 more sources
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. [PDF]
Neuropsychopharmacology, 2022 De Gregorio D +8 more
europepmc +2 more sources
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. [PDF]
Proc Natl Acad Sci U S A, 2021 Significance Social behavior (SB) is a fundamental hallmark of human interaction. Repeated administration of low doses of the 5-HT2A agonist lysergic acid diethylamide (LSD) in mice enhances SB by potentiating 5-HT2A and AMPA receptor neurotransmission ...
De Gregorio D +14 more
europepmc +2 more sources